Datasetsmetadata only
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
19,915Documents
0Full text
2026-09-11Last indexed
Recent documents from this source
- ELVR in PH Patients With Severe Emphysema#414379
- Improving Hypertension Medication Adherence for Older Adults#414378
- Rosemary Infusion for Hypertension With Hypertriglyceridemia#414377
- Can MRI Evaluate Beta-blocker Response in Portal Hypertension?#414376
- Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans#414375
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age#414374
- A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine#414373
- Experimental Vaccine for Prevention of Ebola Virus Infection#414372
- V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)#414371
- Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study#414370
- Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine#414369
- Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule#414368
- Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age#414367
- The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19#414366
- Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses#414365
- Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors#414364
- Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months#414363
- Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine#414362
- To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older#414361
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 Season#414360
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).